| __timestamp | Viking Therapeutics, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1244910 | 17992000000 |
| Thursday, January 1, 2015 | 5029636 | 22400000000 |
| Friday, January 1, 2016 | 4846776 | 23910000000 |
| Sunday, January 1, 2017 | 5329003 | 23813000000 |
| Monday, January 1, 2018 | 7121000 | 24694000000 |
| Tuesday, January 1, 2019 | 9128000 | 23557000000 |
| Wednesday, January 1, 2020 | 10731000 | 25436000000 |
| Friday, January 1, 2021 | 10701000 | 24586000000 |
| Saturday, January 1, 2022 | 16121000 | 27295000000 |
| Sunday, January 1, 2023 | 37021000 | 34205000000 |
| Monday, January 1, 2024 | 28113000000 |
Data in motion
In the competitive world of pharmaceuticals and retail, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Walgreens Boots Alliance, Inc. and Viking Therapeutics, Inc. offer a fascinating study in contrasts. From 2014 to 2023, Walgreens consistently reported SG&A expenses in the range of $17.7 billion to $28.1 billion, reflecting its vast global operations. In contrast, Viking Therapeutics, a smaller biotech firm, maintained SG&A costs between $1.2 million and $37 million, showcasing a leaner approach.
Over the decade, Walgreens' SG&A expenses grew by approximately 44%, while Viking's expenses surged by over 2,800%, indicating aggressive expansion. However, the data for 2024 is incomplete for Viking, suggesting a need for further analysis. This comparison highlights the diverse strategies companies employ to manage operational costs, with Walgreens focusing on scale and Viking on agility.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viking Therapeutics, Inc.
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Who Optimizes SG&A Costs Better? Amgen Inc. or Walgreens Boots Alliance, Inc.
Breaking Down SG&A Expenses: Amgen Inc. vs Viking Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Viking Therapeutics, Inc.
Comparing SG&A Expenses: Catalent, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared